NEU is US based witha US Ceo, the science from NZ , listing AU, but having US Ceo is US.
Thats really a really big plus. OZ and NZ bios have great science. Most failures are due to poor management. Incompeteant boards or being lised on the ASX.
We only have one of those negative factors at play, but CEO Glass is great at raising FREE MONEY.
So ASX irrelevant except for low SP. BUT that is our chance to kill the pig.
drug development in traumatic brain injury, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$15.39 |
Change
0.550(3.71%) |
Mkt cap ! $1.915B | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.50 | $14.91 | $9.641M | 631.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $15.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.39 | 1224 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |